A detailed history of Riverwater Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Riverwater Partners LLC holds 1,062 shares of LLY stock, worth $861,366. This represents 0.52% of its overall portfolio holdings.

Number of Shares
1,062
Previous 1,089 2.48%
Holding current value
$861,366
Previous $985,000 4.57%
% of portfolio
0.52%
Previous 0.83%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$772.14 - $960.02 $20,847 - $25,920
-27 Reduced 2.48%
1,062 $940,000
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $68,137 - $85,449
94 Added 9.45%
1,089 $985,000
Q1 2024

Apr 18, 2024

BUY
$592.2 - $792.28 $589,239 - $788,318
995 New
995 $774,000
Q3 2022

Nov 08, 2022

BUY
$296.48 - $337.87 $617,864 - $704,121
2,084 New
2,084 $674,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Riverwater Partners LLC Portfolio

Follow Riverwater Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverwater Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverwater Partners LLC with notifications on news.